Fonseca, Francisco

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine

Atherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular Health

Cited by 9,482

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine

Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular Diseases

Cited by 6,674

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Ridker, P. M., MacFadyen, J. G., Thuren, T., Everett, B. M., Libby, P., Glynn, R. J., Ridker, P., Lorenzatti, A., Krum, H., Varigos, J., et al. (2017) · The Lancet

Inflammasome and immune disordersInflammatory Biomarkers in Disease Prognosis

Cited by 1,344

The role of soluble fiber intake in patients under highly effective lipid-lowering therapy

Ramos, S. C., Fonseca, F. A., Kasmas, S. H., Moreira, F. T., Helfenstein, T., Borges, N. C., Moreno, R. A., Rezende, V. M., Silva, F. C., & Izar, M. C. (2011) · Nutrition Journal

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 45

Additive effects of plant sterols supplementation in addition to different lipid-lowering regimens

Malina, D. M. T., Fonseca, F. A., Barbosa, S. A., Kasmas, S. H., Machado, V. A., França, C. N., Borges, N. C., Moreno, R. A., & Izar, M. C. (2015) · Journal of clinical lipidology

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 25